Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Chambers

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Health Affairs (Project Hope)|July 7, 2025
Drug Coverage Policies And Clinical Guidelines Alignment: Most Coverage Decisions Include Additional RestrictionsJulia A Rucker, Molly T Beinfeld, Katherine A Clifford, et al.
Journal of Managed Care & Specialty Pharmacy|February 25, 2023
Examining US commercial health plans' use of The Institute for Clinical and Economic Review's reports in specialty drug coverage decisionsJames D Chambers, Daniel E Enright, Ari D Panzer, et al.
Academic Radiology|July 4, 2012
Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limitsHansel Javier Otero, James D Chambers, Brian W Bresnahan, et al.
International Journal of Technology Assessment in Health Care|October 26, 2017
EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTSJames D Chambers, Cayla J Saret, Jordan E Anderson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 27, 2016
The Role of Decision Models in Health Care Policy: A Case StudyAva John-Baptiste, Marilyn M Schapira, Catherine Cravens, et al.
Health Affairs (Project Hope)|July 10, 2018
Specialty Drug Coverage Varies Across Commercial Health Plans In The USJames D Chambers, David D Kim, Elle F Pope, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 16, 2017
The influence of time horizon on results of cost-effectiveness analysesDavid D Kim, Colby L Wilkinson, Elle F Pope, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 18, 2017
A Review of Empirical Analyses of Disinvestment InitiativesJames D Chambers, Mark N Salem, Brittany N D'Cruz, et al.
Health Affairs Scholar|May 17, 2024
Commercial coverage of specialty drugs, 2017-2021Julia A Rucker, Molly T Beinfeld, Nola B Jenkins, et al.
Applied Health Economics and Health Policy|November 11, 2016
Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product ApprovalJames D Chambers, Teja Thorat, Colby L Wilkinson, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Health Affairs (Project Hope)|July 7, 2025
Drug Coverage Policies And Clinical Guidelines Alignment: Most Coverage Decisions Include Additional RestrictionsJulia A Rucker, Molly T Beinfeld, Katherine A Clifford, et al.
Journal of Managed Care & Specialty Pharmacy|February 25, 2023
Examining US commercial health plans' use of The Institute for Clinical and Economic Review's reports in specialty drug coverage decisionsJames D Chambers, Daniel E Enright, Ari D Panzer, et al.
Academic Radiology|July 4, 2012
Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limitsHansel Javier Otero, James D Chambers, Brian W Bresnahan, et al.
International Journal of Technology Assessment in Health Care|October 26, 2017
EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTSJames D Chambers, Cayla J Saret, Jordan E Anderson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 27, 2016
The Role of Decision Models in Health Care Policy: A Case StudyAva John-Baptiste, Marilyn M Schapira, Catherine Cravens, et al.
Health Affairs (Project Hope)|July 10, 2018
Specialty Drug Coverage Varies Across Commercial Health Plans In The USJames D Chambers, David D Kim, Elle F Pope, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 16, 2017
The influence of time horizon on results of cost-effectiveness analysesDavid D Kim, Colby L Wilkinson, Elle F Pope, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 18, 2017
A Review of Empirical Analyses of Disinvestment InitiativesJames D Chambers, Mark N Salem, Brittany N D'Cruz, et al.
Health Affairs Scholar|May 17, 2024
Commercial coverage of specialty drugs, 2017-2021Julia A Rucker, Molly T Beinfeld, Nola B Jenkins, et al.
Applied Health Economics and Health Policy|November 11, 2016
Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product ApprovalJames D Chambers, Teja Thorat, Colby L Wilkinson, et al.
Pageof 9